# CUBICIN
> **NDA021572** · New Drug Application · Sponsor: CUBIST PHARMS LLC · Approved 2003-09-12
## Drug
- **FDA Application Number:** NDA021572
- **Application type:** New Drug Application
- **Brand name:** CUBICIN
- **Generic name:** Daptomycin
- **Active ingredients:** DAPTOMYCIN
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Discontinued
- **Sponsor:** CUBIST PHARMS LLC
- **First approval:** 2003-09-12
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021572)
---
*MORVS · CC0 1.0*